Last reviewed · How we verify
Ketosteril®
At a glance
| Generic name | Ketosteril® |
|---|---|
| Also known as | EV product code: PRD1170237, incremental hemodialysis, low protein diet |
| Sponsor | Fresenius Kabi |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-027-CNI)
- Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
- Observational Study on Chronic Kidney Disease Treatment With a Ketosteril Supplemented Protein-restricted Diet
- Psychological Aspects and Patients Compliance to Restricted-protein Regimens in Chronic Kidney Disease
- Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients (PHASE1, PHASE2)
- Supplemented Very Low Protein Diet and the Progression of Chronic Kidney Disease (PHASE4)
- LPD+α-ketoacids on Autophagy and Improving Muscle Wasting in CKD (PHASE4)
- Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic Nephropathy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |